According to the most recent financial data from April 2026, the EPS for the trailing twelve months is $2.69. Healthequity's EPS for 2025 amounted to $2.5, marking an increase from $1.11 in 2024. During the quarterly period ending on Apr 30, 2026, HQY's EPS stood at $0.82.
Healthequity had an annual EPS of $2.5, indicating an increase of 125.2% from $1.11 in 2024. The quarterly per-share earnings for the period ending Apr 30, 2026, was $0.82, indicating a 32.3% increase from the same quarter last year. HQY's 12-month EPS stands at $2.69 as of April 2026. Healthequity's annual EPS in 2024 stood at $1.11, a 70.8% increase year-over-year.
During the last 12 months, Healthequity has seen an EPS growth of 32.3% (YoY, quarterly). During the last 5 years, the company had an average EPS growth rate of 83.5%. A 10-year view shows that HQY has seen an average EPS growth of 24% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| EZPW Ezcorp Inc | 12.26 | 26.5% | 29% | N/A |
| HQY Healthequity Inc | 35.18 | 125.2% | N/A | 83.5% |
| UHAL Amerco | 297.63 | -85.8% | -64.9% | -46.3% |
All data is based on quarterly TTM periods, unless otherwise specified.